Tailored solutions for the right biomarker strategy
As part of Q2
Solutions end-to-end biomarker capabilities
, we harness our bioanalytical capabilities to aid in the development and implementation of biomarkers.
Solutions is one of the few bioanalytical laboratories successfully employing immunoprecipitation techniques and multidimensional liquid chromatography (LC) for biomarker quantitation. Our team has the experience and knowledge in development and validation of definitive quantitation addressing endogenous analytes including proteins, peptides, lipids, neurotransmitters, steroids, amino acids, and other biomarker analytes. The development of these assays is followed by method validation or qualification, and sample analysis consistent with global regulatory requirements and governed by SOPs.
Delivery excellence to identify & integrate biomarkers
We have a broad set of capabilities to support biomarker identification and analysis.
Our LC/MS Bioanalytical Biomarker Services include:
- Method development
- Method qualification – “fit-for-purpose” and definitive validation
- Automated immunoprecipitation technology
- Enzyme activity assays
- Sample analysis supporting clinical and non-clinical studies
Solutions is your partner of choice for any development program which requires identifying or measuring biomarkers. Through our experience and expertise we can help you understand how these biomarkers can deliver actionable medical insights for better health. Q2
Solutions has developed >150 new biomarker assays every year since 2015.
Learn more about our end-to-end biomarker capabilities